Live news related to SANOFI stock (FR0000120578): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The two groups are adding several long-acting antibodies to their long-standing collaboration, built around Dupixent. The agreement provides for an in…
The Parisian pharmaceutical laboratory is losing ground this Wednesday, amplifying a decline that reflects negative momentum over the month. The sessi…
In an open letter published on September 22, 2026, the chairmen of nine pharmaceutical groups, including Sanofi, call on national leaders to act to st…
Sanofi is losing ground on Tuesday in a globally stable CAC 40, thus amplifying its recent decline. The stock is under pressure from its moving averag…
In a challenging trading session for the Paris index, Sanofi displays significant progress that stands out from the prevailing trend. The stock benefi…
Sanofi would enter Cheplapharm's capital at 26.4% in exchange for the transfer of a selection of mature medicines and three industrial sites. The tran…
The European Commission has approved an extension of indication for Sanofi's meningococcal vaccine MenQuadfi, enabling its use in infants from six wee…
On July 21, Sanofi announced changes to its executive committee, effective September 1, 2026. This reorganization focuses power around business activi…
Following his appointment as Executive Vice President, Global Head of Research & Development Pharma at Sanofi, Paulo Fontoura announced his resignatio…
The French pharmaceutical company marks one of the strongest gains in the CAC 40 by mid-morning. This movement follows the U.S. regulator's approval o…
